does semaglutide cause heart issues GLP-1 agonists like Ozempic may reduce cardiovascular events by 20% Semaglutide and the Heart: Focus

In February of 2025, the FDA declared a shortage of GLP-1 semaglutide, the active ingredient in Ozempic and Wegovy

SIRT1 signaling as potential modulator of skeletal muscle diseases

"You would have to commit to a lifelong taking of this drug, which is something you would contemplate only if the benefits outweigh the risks, as low as this risk could be," Rubino said

Although slower gastric emptying extends satiation after eating to control appetite, it also slows the muscular contractions throughout the rest of the gut while hindering nutrient absorption

By providing the building blocks for NAD+, you may help your body maintain its natural ability to produce cellular energy and manage the effects of daily environmental stress